刘东颖,谢广茹,陈明.71例男性乳腺癌患者临床与预后分析[J].Chinese journal of Epidemiology,2013,34(2):187-190 |
71例男性乳腺癌患者临床与预后分析 |
Analysis on the elinical and prognostic features of 71 male patients with breast cancer |
Received:November 19, 2012 |
DOI:10.3760/cma.j.issn.0254-6450.2013.02.019 |
KeyWord: 乳腺肿瘤 男性 激素受体 人类表皮生长因子受体一2 |
English Key Word: Male breast neoplasia Hormone receptor Human epidermal growth factorreceptor-2 |
FundProject: |
|
Hits: 2861 |
Download times: 1120 |
Abstract: |
目的探讨男性乳腺癌(MBC)患者临床病理特征及其预后。方法回顾性分析天津医科大学附属肿瘤医院2002年3月至2012年3月71例MBC患者的临床病理及生存资料。结果MBC患者年龄43~84(M=62)岁,中位年龄大于同期女性乳腺癌(FBC)患者(t=6.355,P=0.000),与同期FBC例数之比为o.42%(71:16 796);MBC病理类型以浸润性导管癌(x2=29.875,P=0.000)、临床分期以>ⅢA(x2=13.377,P=0.037)多见。MBC患者雌激素受体阳性率明显高于FBC患者,而人类表皮生长因子受体-2(HER-2)阳性率明显低于FBC患者x2=3.741,P=0.048;x2=12.845,P-0.002)。单因素和多因素分析发现MBC患者预后比FBC患者差(P-0.004,P=0.046)。MBC患者的HER-2表达水平是影响其预后的重要因素(x2=4.219,P=0.040)。结论MBC与FBC的临床特征及预后均存在显著差异。HER一2阳性可能对MBC的预后及治疗有重要意义。 |
English Abstract: |
Objective Male breast cancer(MBC)iS a rare disease,with clinical and prognostic features still controversial.The aim of this study was to discuss the clinical characteristies
and prognosis of MBC.Methods Clinical data related to 7 l MBC patients was reviewed.Results The radio of MBC to female breast cancer(FBC)was 42:1 0 000.Age related to the diagnosis of MBC ranged from 43 to 84 years with the median age as 62 years old.older than the FBC patients(t=6.355.P=0.000).The percentage ofinvasive ducal carcinoma in MBC patients was much higher than in FBC patients(X 2=29.875,P=0.000).The positive rate of estrogen receptor(ER)was significantly higher than those in FBC patients and the positive rates of human epidermal growth factor receptor-2(HER-2)were less frequently(X2=3.741,P=0.048 and X2=12.845,P=0.002) seen.Data from the univariate and multivariate analysis showed that the 3-.5-and 10-year survival rates of MBC were 82.6%.74.O%and 47.4%respectively。significantly higher than those in FBC patients(P=0.004.P=0.046).Patients with positive HER-2 showed worse prognosis than HER-2
negative patients in MBC patients(X2=4.219,P=0.040).Conclusion There were significant
clinic-pathologic and prognostic differences between FBC and MBC patients.The HER-2 positivity seemed to be an important factor for the prognosis and treatment of patients with MBC. |
View Fulltext
Html FullText
View/Add Comment Download reader |
Close |